MetricSide LogoMetricSide
Learn
  1. Home
  2. Stocks
  3. Healthcare
  4. RVMD
OverviewMetricsPricesGrowthEfficiencyValuationBalanceCash & Capital
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Revolution Medicines, Inc. (RVMD) Financial Metrics

Key metrics and charts across all fundamental categories.

Prices

Stock price and market valuation

Stock Price
$169.77
380.1%
Market Cap
$33.63B
405.5%

RVMD trades at $169.77, a 380.1% increase year-over-year. Market capitalization stands at $33.63B, up 405.5% from the prior year. Track RVMD price trends and market cap history to understand how the market values this company over time.

Stock Price
How the market values the company over time
Market Cap
Total equity value as determined by the market

Growth

Revenue and earnings growth across quarters

TTM Revenue
$0
Q. Revenue
$0
TTM EBITDA
$-1.37B
76.0%
Q. Op. Income
$-445.22M
TTM Net Income
$-1.37B
96.7%
Q. Net Income
$-453.82M

$0 in TTM revenue declined NaN% YoY, reaching $0 last quarter. TTM EBITDA of $-1.37B on operating income of $-445.22M shows growth is flowing through. However, net income is negative at $1.37B — growth is not yet reaching the bottom line. Revenue is contracting — assess whether this is cyclical or structural.

TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes

Balance Sheet

Assets, cash, debt, and leverage

Total Assets
$2.25B
Long-Term Debt
N/A
D/E
N/A
Equity
$1.50B
Total Assets
Expanding asset base can indicate business growth
Cash & Equivalents
Shows liquidity available for opportunities or downturns
Long-Term Debt
Declining debt trend is generally positive
Debt / Equity
Lower means less reliance on borrowed money
Debt / EBITDA
Below 2x is conservative; above 4x is high

Valuation

Price multiples and return ratios

Market Cap
$33.63B
P/E
N/A
P/S
N/A
P/B
22.4x

P/S of 0.0x and P/B of 22.4x.

P/E Ratio
Higher suggests growth expectations; lower may signal undervaluation
P/S Ratio
Useful when earnings are volatile or negative
P/B Ratio
Below 1 means trading below accounting book value
EV / EBITDA
Lower multiple often signals better value
FCF Yield (%)
Cash return at current price — compare to bond yields
Earnings Yield (%)
Earnings return at current price — inverse of P/E
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage

Efficiency

Operating efficiency and return metrics

Op. Margin
-44522200000.0%
84.9%
Net Margin
-45381600000.0%
112.6%
ROE
-91.5%
172.5%
Gross Margin
N/A

Op. margin of -44522200000.0% is down 20446200000.0% YoY — costs are rising relative to revenue. Net margin at -45381600000.0%. Negative ROE of -91.5% indicates shareholder value is being eroded.

Margins (%)
Operating vs Net Margin — how much of each dollar becomes profit
EBITDA Margin (%)
Operating profitability independent of capital structure
Asset Turnover
How efficiently assets generate each dollar of sales
Return on Assets (ROA)
How well management uses assets to generate profit
Revenue per Share
Per-share revenue growth adjusted for dilution

Cash & Capital

Free cash flow, earnings quality, and capital allocation

Free Cash Flow
$-355.70M
79.9%
Op. Cash Flow
$-354.17M
Shares Out.
198.10M
5.3%
Cash & Equiv.
$440.94M

FCF of $-355.70M on $-354.17M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $440.94M provide financial flexibility. Shares outstanding rose 5.3% YoY — shareholder dilution is eroding per-share value.

Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (%)
10%+ signals a capital-efficient business model
FCF / Net Income
Above 1 means earnings are backed by real cash
Shares Outstanding
Declining means buybacks benefit remaining holders
Book Value (Equity)
Growing book value signals intrinsic value creation